Obesity and its fatal sequelae are among the most prevalent and challenging morbidities confronting the medical profession in the 21^^ century. Obesity leads to insulin resistance, hyperglycemia, and dyslipidemia. To lower blood glucose, the pancreas produces excess insulin which stimulates the liver to convert excess glucose to FAs and TGs. The increased FAs produce two potentially fatal sequelae: 1) elevated plasma lipids and atherosclerosis, leading to death from myocardial infarction or stroke; and 2) fatty liver, which can lead to death from cirrhosis and liver failure. The burden of these FA-related complications is enormous. More than half of the deaths in obese type 2 diabetics are attributable to cardiovascular disease (1). Moreover, more than one-third of the US population accumulates excess TGs in liver (2) a condition known as non-alcoholic fatty liver disease (NAFLD), which accounts for 10% of the liver transplants in the US (3). If we are to combat the deadly consequences of excess FA synthesis, we must understand the regulatory factors that trigger this response. Our Program Project Grant made an important start with two discoveries: 1) that SREBP-lc is the key protein mediating insulin stimulation of FA synthesis in the liver;and 2) that an SREBP-lc target gene, MIG12, encodes a protein that markedly stimulates the activity of acetyl-CoA carboxylase (ACC), the first committed enzyme in FA synthesis. If we successfully complete the studies outlined in Research Project 3, we will have laid the basis for a new strategy to prevent the excess synthesis of FAs, and ameliorate the fatal consequences of obesity and diabetes.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Program Projects (P01)
Project #
Application #
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Texas Sw Medical Center Dallas
United States
Zip Code
Smagris, Eriks; BasuRay, Soumik; Li, John et al. (2015) Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis. Hepatology 61:108-18
Ulrich, Victoria; Konaniah, Eddy S; Herz, Joachim et al. (2014) Genetic variants of ApoE and ApoER2 differentially modulate endothelial function. Proc Natl Acad Sci U S A 111:13493-8
Ulrich, Victoria; Konaniah, Eddy S; Lee, Wan-Ru et al. (2014) Antiphospholipid antibodies attenuate endothelial repair and promote neointima formation in mice. J Am Heart Assoc 3:e001369
Gusarova, Viktoria; Alexa, Corey A; Na, Erqian et al. (2014) ANGPTL8/betatrophin does not control pancreatic beta cell expansion. Cell 159:691-6
Reboldi, Andrea; Dang, Eric V; McDonald, Jeffrey G et al. (2014) Inflammation. 25-Hydroxycholesterol suppresses interleukin-1-driven inflammation downstream of type I interferon. Science 345:679-84
Xu, Min; Nagati, Jason S; Xie, Jian et al. (2014) An acetate switch regulates stress erythropoiesis. Nat Med 20:1018-26
Kozlitina, Julia; Smagris, Eriks; Stender, Stefan et al. (2014) Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 46:352-6
Das, Akash; Brown, Michael S; Anderson, Donald D et al. (2014) Three pools of plasma membrane cholesterol and their relation to cholesterol homeostasis. Elife 3:
Maetzel, Dorothea; Sarkar, Sovan; Wang, Haoyi et al. (2014) Genetic and chemical correction of cholesterol accumulation and impaired autophagy in hepatic and neural cells derived from Niemann-Pick Type C patient-specific iPS cells. Stem Cell Reports 2:866-80
Lane-Donovan, Courtney; Philips, Gary T; Herz, Joachim (2014) More than cholesterol transporters: lipoprotein receptors in CNS function and neurodegeneration. Neuron 83:771-87

Showing the most recent 10 out of 670 publications